Literature DB >> 3514676

Partial factor IX protein in a pedigree with hemophilia B due to a partial gene deletion.

G L Bray, A R Thompson.   

Abstract

A partial gene product was identified in a pedigree with hemophilia B due to a partial deletion of the Factor IX gene (Chen, S.-H.,S. Yoshitake, P.F. Chance, G.L. Bray, A.R. Thompson, C.R. Scott, and K. Kurachi, 1985, J. Clin. Invest., 76:2161-2164). Levels of this mutant protein in plasma of affected family members studied ranged from 24 to 36 ng/ml (0.6-0.9 U/dl or percent of normal) by a solid-phase immunoassay which is sensitive and specific for the calcium-dependent conformation of human Factor IX. No Factor IX antigen could be detected in patients' plasmas by a non-calcium-requiring monoclonal anti-Factor IX antibody (less than 2 ng/ml). The unconcentrated urine from the five affected family members and four obligate heterozygotes the five affected family members and four obligate heterozygotes tested contained calcium-dependent Factor IX antigen levels ranging from 64 to 160 ng/ml (1.6-4.0 U/dl) and from 10 to 68 ng/ml (0.25-1.7 U/dl), respectively. Of nine normal volunteers screened, three had detectable calcium-dependent antigen in unconcentrated first morning-voided urines with 9.6-16.8 ng/ml (0.24-0.42 U/dl), while the remaining six had detectable urinary antigen only after a 10-fold concentration. Abnormal and normal urinary Factor IX antigen species were concentrated, immunoaffinity purified, electrophoresed, immunoblotted, and distinguished by autoradiography after incubation with 125I-polyclonal calcium-requiring anti-Factor IX. After reducing purified or concentrated samples, a single abnormal 36,000-mol-wt band was identified in the urines from the four affected family members and four obligate heterozygotes tested. Electrophoresis of the reduced urinary Factor IX antigen from the one normal subject tested showed a broad 15,000-20,000-mol-wt band. This normal band was smaller than the species in patients' urines, and was seen as a minor component in the samples from the heterozygotes. No abnormal antigen could be detected in urine from the two other female family members tested. Thus, abnormal urinary Factor IX antigen represents a marker for the presence of the hemophilic Factor IX gene in this family.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3514676      PMCID: PMC424456          DOI: 10.1172/JCI112421

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  22 in total

1.  Rapid isolation of antigens from cells with a staphylococcal protein A-antibody adsorbent: parameters of the interaction of antibody-antigen complexes with protein A.

Authors:  S W Kessler
Journal:  J Immunol       Date:  1975-12       Impact factor: 5.422

2.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

3.  The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis.

Authors:  K Weber; M Osborn
Journal:  J Biol Chem       Date:  1969-08-25       Impact factor: 5.157

4.  Overview of inhibitors to factor VIII and IX.

Authors:  H R Roberts; R Cromartie
Journal:  Prog Clin Biol Res       Date:  1984

5.  Labeled factor IX kinetics in patients with hemophilia-B.

Authors:  K J Smith; A R Thompson
Journal:  Blood       Date:  1981-09       Impact factor: 22.113

6.  Carrier detection by direct gene analysis in a family with haemophilia B (factor IX deficiency).

Authors:  I R Peake; B L Furlong; A L Bloom
Journal:  Lancet       Date:  1984-02-04       Impact factor: 79.321

7.  Monoclonal antibody to an epitope on the heavy chain of factor IX missing in three hemophilia-B patients.

Authors:  A R Thompson
Journal:  Blood       Date:  1983-11       Impact factor: 22.113

8.  Gene deletions in patients with haemophilia B and anti-factor IX antibodies.

Authors:  F Giannelli; K H Choo; D J Rees; Y Boyd; C R Rizza; G G Brownlee
Journal:  Nature       Date:  1983 May 12-18       Impact factor: 49.962

9.  Factor XII and other hemostatic protein abnormalities in nephrotic syndrome patients.

Authors:  A R Thompson
Journal:  Thromb Haemost       Date:  1982-08-24       Impact factor: 5.249

10.  The gene structure of human anti-haemophilic factor IX.

Authors:  D S Anson; K H Choo; D J Rees; F Giannelli; K Gould; J A Huddleston; G G Brownlee
Journal:  EMBO J       Date:  1984-05       Impact factor: 11.598

View more
  2 in total

1.  Hemophilia B (factor IXSeattle 2) due to a single nucleotide deletion in the gene for factor IX.

Authors:  B G Schach; S Yoshitake; E W Davie
Journal:  J Clin Invest       Date:  1987-10       Impact factor: 14.808

2.  Heterogeneity of the factor IX locus in nine hemophilia B inhibitor patients.

Authors:  R J Matthews; D S Anson; I R Peake; A L Bloom
Journal:  J Clin Invest       Date:  1987-03       Impact factor: 14.808

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.